Thank you to all of you who completed PHCN’s Ombitasvir / Paritaprevir / Ritonavir and Dasabuvir survey and shared it with others. It was truly an honour to read your responses and to use them to write the patient group input report for the Canadian Agency for Drugs and Technologies in Health (CADTH) on your behalf.
The patient group input reports requested by CADTH are an important step towards getting new treatments for hep C more widely available in Canada and BC.
You can find a slightly shortened version of the report on PHCN’s Resources page.
The report was sent in this morning. We now wait to hear the outcome of the treatment’s submission. The Hepatitis C Treatment Information Project will keep you apprised of any news.
PHCN’s Hepatitis C Treatment Information Project is a source of information that doesn’t post a ‘site last modified date’ because it is truly forever changing. Pay it a visit for more information about currently approved hep C treatments in BC, new and emerging drugs, the drug approval process in Canada and BC, resources to help in getting ready for treatment, or just to try to figure out what pages have been newly added in the last week or two! You can also email us your questions about hep C treatments.
Thank you for taking the time to voice your opinion and help advocate for a better tomorrow.